Skip to main content
Erschienen in: Child's Nervous System 6/2017

28.04.2017 | Original Paper

Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience

verfasst von: Nisreen Amayiri, Maisa Swaidan, Yocoub Yousef, Hadeel Halalsheh, Ramiz Abu-Hijlih, Sima Kalaldeh, Maha Barbar, Maher Elayyan, Nesreen Faqih, Maysa Al-Hussaini, Mustafa Mehyar, Ute Bartels, James Drake, Awni Musharbash, Eric Bouffet

Erschienen in: Child's Nervous System | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Management of craniopharyngioma in children is challenging, and their quality of life can be significantly affected. Series describing this from low-middle income countries (LMIC) are few.

Patients and methods

The study provides a retrospective chart review of pediatric patients <18 years old, diagnosed with craniopharyngioma between 2003 and 2014, and treated at King Hussein Cancer Center, Jordan.

Results

Twenty-four patients (12 males) were identified. Median age at diagnosis was 7.4 years (0.9–16.4 years). Commonest symptoms were visual impairment and headache (71%). Review of seventeen preoperative MRIs showed hypothalamic involvement in 88% and hydrocephalus in 76%. Thirteen patients (54%) had multiple surgical interventions. Five patients (21%) had initial gross total resection. Eleven patients (46%) received radiotherapy and six (25%) intra-cystic interferon. Five years’ survival was 87 ± 7% with a median follow-up of 4.5 years (0.3–12.3 years). Four patients (17%) died; one after post-operative cerebral infarction and three secondary to hypothalamic damage. At their last evaluation, all but one patient required multiple hormonal supplements. Ten patients (42%) had best eye visual acuity (VA) >20/40, and four (16%) were legally blind. Eleven patients (46%) were overweight/obese; one had gastric bypass surgery. Seven patients had hyperlipidemia, and eight developed fatty liver infiltration. Eleven patients (65%) were attending schools and one at college. Nine of the living patients (53%) expressed difficulty to engage in the community.

Conclusions

Management of pediatric craniopharyngioma is particularly complex and demanding in LMIC. Multidisciplinary care is integral to optimize the care and minimize the morbidities. A management outline for LMIC is proposed.
Literatur
2.
Zurück zum Zitat Yano S, Kudo M, Hide T, Shinojima N, Makino K, Nakamura H et al (2016) Quality of life and clinical features of long-term survivors surgically treated for pediatric craniopharyngioma. World Neurosurg 85:153–162CrossRefPubMed Yano S, Kudo M, Hide T, Shinojima N, Makino K, Nakamura H et al (2016) Quality of life and clinical features of long-term survivors surgically treated for pediatric craniopharyngioma. World Neurosurg 85:153–162CrossRefPubMed
3.
Zurück zum Zitat Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE (2013) Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 85(5):1301–1306CrossRefPubMed Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE (2013) Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 85(5):1301–1306CrossRefPubMed
4.
Zurück zum Zitat Muller HL (2015) Craniopharyngioma: long-term consequences of a chronic disease. Expert Rev Neurother 15(11):1241–1244CrossRefPubMed Muller HL (2015) Craniopharyngioma: long-term consequences of a chronic disease. Expert Rev Neurother 15(11):1241–1244CrossRefPubMed
5.
Zurück zum Zitat Clark AJ, Cage TA, Aranda D, Parsa AT, Auguste KI, Gupta N (2012) Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr 10(4):293–301CrossRefPubMed Clark AJ, Cage TA, Aranda D, Parsa AT, Auguste KI, Gupta N (2012) Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr 10(4):293–301CrossRefPubMed
6.
Zurück zum Zitat Zhang YQ, Ma ZY, Wu ZB, Luo SQ, Wang ZC (2008) Radical resection of 202 pediatric craniopharyngiomas with special reference to the surgical approaches and hypothalamic protection. Pediatr Neurosurg 44(6):435–443CrossRefPubMed Zhang YQ, Ma ZY, Wu ZB, Luo SQ, Wang ZC (2008) Radical resection of 202 pediatric craniopharyngiomas with special reference to the surgical approaches and hypothalamic protection. Pediatr Neurosurg 44(6):435–443CrossRefPubMed
7.
Zurück zum Zitat Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D et al (2010) Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 28(4):E5CrossRefPubMed Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D et al (2010) Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 28(4):E5CrossRefPubMed
8.
Zurück zum Zitat Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40(4):214–218CrossRefPubMed Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40(4):214–218CrossRefPubMed
9.
Zurück zum Zitat Moon SH, Kim IH, Park SW, Kim I, Hong S, Park CI et al (2005) Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas—a study in single institute. Childs Nerv Syst 21(8–9):799–807CrossRefPubMed Moon SH, Kim IH, Park SW, Kim I, Hong S, Park CI et al (2005) Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas—a study in single institute. Childs Nerv Syst 21(8–9):799–807CrossRefPubMed
10.
Zurück zum Zitat Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW et al (2002) Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 53(3):533–542CrossRefPubMed Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW et al (2002) Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 53(3):533–542CrossRefPubMed
11.
Zurück zum Zitat Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne) 3:39 Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne) 3:39
12.
Zurück zum Zitat Cavalheiro S, Di Rocco C, Valenzuela S, Dastoli PA, Tamburrini G, Massimi L et al (2010) Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurg Focus 28(4):E12CrossRefPubMed Cavalheiro S, Di Rocco C, Valenzuela S, Dastoli PA, Tamburrini G, Massimi L et al (2010) Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurg Focus 28(4):E12CrossRefPubMed
13.
Zurück zum Zitat Zhang YQ, Wang CC, Ma ZY (2002) Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatr Neurosurg 36(2):80–84CrossRefPubMed Zhang YQ, Wang CC, Ma ZY (2002) Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatr Neurosurg 36(2):80–84CrossRefPubMed
14.
Zurück zum Zitat Adeloye A, Nottidge VA, Udi J (1988) Craniopharyngioma in Nigerian children. Childs Nerv Syst 4(3):128–134CrossRefPubMed Adeloye A, Nottidge VA, Udi J (1988) Craniopharyngioma in Nigerian children. Childs Nerv Syst 4(3):128–134CrossRefPubMed
15.
Zurück zum Zitat Hafez MA, ElMekkawy S, AbdelBadie H, Mohy M, Omar M (2006) Pediatric craniopharyngioma—rationale for multimodal management: the Egyptian experience. J Pediatr Endocrinol Metab 19(Suppl 1):371–380PubMed Hafez MA, ElMekkawy S, AbdelBadie H, Mohy M, Omar M (2006) Pediatric craniopharyngioma—rationale for multimodal management: the Egyptian experience. J Pediatr Endocrinol Metab 19(Suppl 1):371–380PubMed
16.
Zurück zum Zitat Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F, Vasigh A, Aghakhani S (2004) Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care (Engl) 13(1):11–15CrossRef Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F, Vasigh A, Aghakhani S (2004) Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care (Engl) 13(1):11–15CrossRef
17.
Zurück zum Zitat Ersahin Y, Yurtseven T, Ozgiray E, Mutluer S (2005) Craniopharyngiomas in children: Turkey experience. Childs Nerv Syst 21(8–9):766–772CrossRefPubMed Ersahin Y, Yurtseven T, Ozgiray E, Mutluer S (2005) Craniopharyngiomas in children: Turkey experience. Childs Nerv Syst 21(8–9):766–772CrossRefPubMed
18.
Zurück zum Zitat Khafaga Y, Jenkin D, Kanaan I, Hassounah M, Al Shabanah M, Gray A (1998) Craniopharyngioma in children. Int J Radiat Oncol Biol Phys 42(3):601–606CrossRefPubMed Khafaga Y, Jenkin D, Kanaan I, Hassounah M, Al Shabanah M, Gray A (1998) Craniopharyngioma in children. Int J Radiat Oncol Biol Phys 42(3):601–606CrossRefPubMed
19.
Zurück zum Zitat Gupta DK, Ojha BK, Sarkar C, Mahapatra AK, Sharma BS, Mehta VS (2006) Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features. Childs Nerv Syst 22(1):50–55CrossRefPubMed Gupta DK, Ojha BK, Sarkar C, Mahapatra AK, Sharma BS, Mehta VS (2006) Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features. Childs Nerv Syst 22(1):50–55CrossRefPubMed
20.
Zurück zum Zitat Cohen M, Bartels U, Branson H, Kulkarni AV, Hamilton J (2013) Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011. Neuro-Oncology 15(6):767–774CrossRefPubMedPubMedCentral Cohen M, Bartels U, Branson H, Kulkarni AV, Hamilton J (2013) Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011. Neuro-Oncology 15(6):767–774CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Puget S (2012) Treatment strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne) 3:64 Puget S (2012) Treatment strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne) 3:64
22.
Zurück zum Zitat Crom DB, Smith D, Xiong Z, Onar A, Hudson MM, Merchant TE et al (2010) Health status in long-term survivors of pediatric craniopharyngiomas. J Neurosci Nurs 42(6):323–328 quiz 9-30CrossRefPubMedPubMedCentral Crom DB, Smith D, Xiong Z, Onar A, Hudson MM, Merchant TE et al (2010) Health status in long-term survivors of pediatric craniopharyngiomas. J Neurosci Nurs 42(6):323–328 quiz 9-30CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat De Vile CJ, Grant DB, Kendall BE, Neville BG, Stanhope R, Watkins KE et al (1996) Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg 85(1):73–81CrossRefPubMed De Vile CJ, Grant DB, Kendall BE, Neville BG, Stanhope R, Watkins KE et al (1996) Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg 85(1):73–81CrossRefPubMed
24.
Zurück zum Zitat Sanford RA (1994) Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 21(Suppl 1):39–43PubMed Sanford RA (1994) Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 21(Suppl 1):39–43PubMed
25.
Zurück zum Zitat Finken MJ, Zwaveling-Soonawala N, Walenkamp MJ, Vulsma T, van Trotsenburg AS, Rotteveel J (2011) Frequent occurrence of the triphasic response (diabetes insipidus/hyponatremia/diabetes insipidus) after surgery for craniopharyngioma in childhood. Horm Res Paediatr 76(1):22–26CrossRefPubMed Finken MJ, Zwaveling-Soonawala N, Walenkamp MJ, Vulsma T, van Trotsenburg AS, Rotteveel J (2011) Frequent occurrence of the triphasic response (diabetes insipidus/hyponatremia/diabetes insipidus) after surgery for craniopharyngioma in childhood. Horm Res Paediatr 76(1):22–26CrossRefPubMed
26.
Zurück zum Zitat Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276–279CrossRefPubMed Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276–279CrossRefPubMed
27.
Zurück zum Zitat Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM, Muller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-Oncology 17(7):1029–1038CrossRefPubMed Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM, Muller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-Oncology 17(7):1029–1038CrossRefPubMed
28.
Zurück zum Zitat Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C et al (2013) Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab 98(6):2376–2382CrossRefPubMed Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C et al (2013) Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab 98(6):2376–2382CrossRefPubMed
29.
Zurück zum Zitat Muller HL (2016) Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome. Endocrine 51(1):1–3CrossRefPubMed Muller HL (2016) Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome. Endocrine 51(1):1–3CrossRefPubMed
Metadaten
Titel
Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience
verfasst von
Nisreen Amayiri
Maisa Swaidan
Yocoub Yousef
Hadeel Halalsheh
Ramiz Abu-Hijlih
Sima Kalaldeh
Maha Barbar
Maher Elayyan
Nesreen Faqih
Maysa Al-Hussaini
Mustafa Mehyar
Ute Bartels
James Drake
Awni Musharbash
Eric Bouffet
Publikationsdatum
28.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 6/2017
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-017-3411-4

Weitere Artikel der Ausgabe 6/2017

Child's Nervous System 6/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.